Source link : https://www.newshealth.biz/health-news/diabetes-drug-class-may-reduce-need-for-gout-medications/
WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and gout, new research has found. Data from a large US claims database showed that SGLT2i use was associated with a 31% lower rate of initiation […]
Author : News Health
Publish date : 2024-11-19 13:35:06
Copyright for syndicated content belongs to the linked Source.